Chain-end-labeled
polymers are interesting for a range of applications.
In polymer nanomedicine, chain-end-labeled polymers are useful to
study and help understand cellular internalization and intracellular
trafficking processes. The recent advent of fluorescent label-free
techniques, such as nanoscale secondary ion mass spectrometry (NanoSIMS),
provides access to high-resolution intracellular mapping that can
complement information obtained using fluorescent-labeled materials
and confocal microscopy and flow cytometry. Using poly(
N
-(2-hydroxypropyl)methacrylamide) (PHPMA) as a prototypical polymer
nanomedicine, this paper presents a synthetic strategy to polymers
that contain trace element labels, such as fluorine, which can be
used for NanoSIMS analysis. The strategy presented in this paper is
based on reversible addition fragmentation chain transfer (RAFT) polymerization
of pentafluorophenyl methacrylate (PFMA) mediated by two novel chain-transfer
agents (CTAs), which contain either one (α) or two (α,ω)
fluorine labels. In the first part of this study, via a number of
polymerization experiments, the polymerization properties of the fluorinated
RAFT CTAs were established.
19
F NMR spectroscopy revealed
that these fluorinated RAFT agents possess unique spectral signatures,
which allow to directly monitor RAFT agent conversion and measure
end-group fidelity. Comparison with 4-cyanopentanoic acid dithiobenzoate,
which is a standard CTA for the RAFT polymerization of PFMA, revealed
that the introduction of one or two fluorine labels does not significantly
affect the polymerization properties of the CTA. In the last part
of this paper, a proof-of-concept study is presented that demonstrates
the feasibility of the fluorine-labeled poly(pentafluorophenyl methacrylate)
polymers as platforms for the postpolymerization modification to generate
PHPMA-based polymer nanomedicines.